Open Access
| Numéro |
Med Sci (Paris)
Volume 37, Numéro 2, Février 2021
|
|
|---|---|---|
| Page(s) | 130 - 133 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/2020276 | |
| Publié en ligne | 16 février 2021 | |
- Kaplon H, Dieu-Nosjean MC. Quel avenir pour les lymphocytes B infiltrant les tumeurs solides : marqueur pronostique et/ou cible thérapeutique ?. Med Sci (Paris) 2018 ; 34 : 72–78. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Dieu-Nosjean MC, Antoine M, Danel C, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008 ; 26 : 4410–4417. [CrossRef] [PubMed] [Google Scholar]
- Germain C, Gnjatic S, Tamzalit F, et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med 2014 ; 189 : 832–844. [CrossRef] [PubMed] [Google Scholar]
- Teillaud JL, Dieu-Nosjean MC. Tertiary lymphoid structures: An anti-tumor school for adaptive immune cells and an antibody factory to fight cancer?. Front Immunol 2017 ; 8 : 830. [CrossRef] [PubMed] [Google Scholar]
- Cottrell TR, Thompson ED, Forde PM, et al. Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC). Ann Oncol 2018 ; 29 : 1853–1860. [CrossRef] [PubMed] [Google Scholar]
- Amaria RN, Reddy SM, Tawbi HA, et al. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med 2018 ; 24 : 1649–1654. [CrossRef] [PubMed] [Google Scholar]
- Reddy SM, Reuben A, Barua S, et al. Poor response to neoadjuvant chemotherapy correlates with mast cell infiltration in inflammatory breast cancer. Cancer Immunol Res 2019 ; 7 : 1025–1035. [CrossRef] [PubMed] [Google Scholar]
- Song IH, Heo SH, Bang WS, et al. Predictive value of tertiary lymphoid structures assessed by high endothelial venule counts in the neoadjuvant setting of triple-negative breast cancer. Cancer Res Treat 2017 ; 49 : 399–407. [PubMed] [Google Scholar]
- Cabrita R, Lauss M, Sanna A, et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 2020; 577 : 561–5. [CrossRef] [PubMed] [Google Scholar]
- Helmink BA, Reddy SM, Gao J, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature 2020; 577 : 549–55. [CrossRef] [PubMed] [Google Scholar]
- Petitprez F, de Reyniès A, Keung EZ, et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature 2020; 577 : 556–60. [CrossRef] [PubMed] [Google Scholar]
- Picard E, Verschoor CP, Ma GW, Pawelec G. Relationships between immune landscapes, genetic subtypes and responses to immunotherapy in colorectal cancer. Front Immunol 2020; 11 : 369. [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.